Modified Vaccinia Virus Ankara (Q28223836)

Characterization of the vaccinia MVA hemagglutinin gene locus and its evaluation as an insertion site for foreign genes

page(s)

187-243

0 references

cites work

1 reference

12 December 2020

Strong, but Age-Dependent, Protection Elicited by a Deoxyribonucleic Acid/Modified Vaccinia Ankara Simian Immunodeficiency Virus Vaccine

1 reference

12 December 2020

Host range and cytopathogenicity of the highly attenuated MVA strain of vaccinia virus: propagation and generation of recombinant viruses in a nonhuman mammalian cell line

1 reference

12 December 2020

Comparative assessment of transmission-blocking vaccine candidates against Plasmodium falciparum

1 reference

12 December 2020

Safety and efficacy of MVA85A, a new tuberculosis vaccine, in infants previously vaccinated with BCG: a randomised, placebo-controlled phase 2b trial

1 reference

12 December 2020

1 reference

12 December 2020

The E3L gene of vaccinia virus encodes an inhibitor of the interferon-induced, double-stranded RNA-dependent protein kinase

1 reference

12 December 2020

Soluble interferon-gamma receptors encoded by poxviruses

1 reference

12 December 2020

HIV-1 vaccines: challenges and new perspectives

1 reference

12 December 2020

Inactivation of the viral interleukin 1beta receptor improves CD8+ T-cell memory responses elicited upon immunization with modified vaccinia virus Ankara

1 reference

12 December 2020

The use of nonhuman primate models of HIV infection for the evaluation of antiviral strategies

1 reference

12 December 2020

Comparison of lyophilized versus liquid modified vaccinia Ankara (MVA) formulations and subcutaneous versus intradermal routes of administration in healthy vaccinia-naïve subjects

1 reference

12 December 2020

Efficiently editing the vaccinia virus genome by using the CRISPR-Cas9 system.

1 reference

12 December 2020

Isolation of MERS coronavirus from a dromedary camel, Qatar, 2014

1 reference

12 December 2020

Normal keratinization in a spontaneously immortalized aneuploid human keratinocyte cell line

1 reference

12 December 2020

Structure of vaccinia virus late promoters

1 reference

12 December 2020

Role of viral factor E3L in modified vaccinia virus ankara infection of human HeLa Cells: regulation of the virus life cycle and identification of differentially expressed host genes

1 reference

12 December 2020

Pigs, poultry, and pandemic influenza: how zoonotic pathogens threaten human health

1 reference

12 December 2020

SAMD9 is an innate antiviral host factor with stress response properties that can be antagonized by poxviruses.

1 reference

12 December 2020

A chemically defined production process for highly attenuated poxviruses.

1 reference

12 December 2020

Vaccinal Infection of the Chorio-Allantoic Membrane of the Chick Embryo

1 reference

12 December 2020

Potent functional antibody responses elicited by HIV-I DNA priming and boosting with heterologous HIV-1 recombinant MVA in healthy Tanzanian adults

1 reference

12 December 2020

DNA/MVA Vaccines for HIV/AIDS

1 reference

12 December 2020

Critical role of perforin-dependent CD8+ T cell immunity for rapid protective vaccination in a murine model for human smallpox

1 reference

12 December 2020

Vaccinia virus encodes a previously uncharacterized mitochondrial-associated inhibitor of apoptosis

1 reference

12 December 2020

Comparison of vaccine strategies using recombinant env-gag-pol MVA with or without an oligomeric Env protein boost in the SHIV rhesus macaque model

1 reference

12 December 2020

CULTIVATION OF VACCINE VIRUS FOR JENNERIAN PROPHYLAXIS IN MAN.

1 reference

12 December 2020

Safety and immunogenicity of modified vaccinia Ankara as a smallpox vaccine in people with atopic dermatitis

1 reference

12 December 2020

Immunogenicity and protective efficacy of recombinant Modified Vaccinia virus Ankara candidate vaccines delivering West Nile virus envelope antigens

1 reference

12 December 2020

New avian suspension cell lines provide production of influenza virus and MVA in serum-free media: studies on growth, metabolism and virus propagation

1 reference

12 December 2020

Deletion of the vaccinia virus N2L gene encoding an inhibitor of IRF3 improves the immunogenicity of modified vaccinia virus Ankara expressing HIV-1 antigens.

1 reference

12 December 2020

Preliminary assessment of the efficacy of a T-cell-based influenza vaccine, MVA-NP+M1, in humans

1 reference

12 December 2020

CD40L-adjuvanted DNA/modified vaccinia virus Ankara simian immunodeficiency virus (SIV) vaccine enhances protection against neutralization-resistant mucosal SIV infection

1 reference

12 December 2020

Molecular genetics of vaccinia virus: demonstration of marker rescue

1 reference

12 December 2020

Priming with a simplified intradermal HIV-1 DNA vaccine regimen followed by boosting with recombinant HIV-1 MVA vaccine is safe and immunogenic: a phase IIa randomized clinical trial

1 reference

12 December 2020

Modified vaccinia virus ankara (MVA) as production platform for vaccines against influenza and other viral respiratory diseases

1 reference

12 December 2020

Boosting with poxviruses enhances Mycobacterium bovis BCG efficacy against tuberculosis in guinea pigs

1 reference

12 December 2020

The T1/35kDa family of poxvirus-secreted proteins bind chemokines and modulate leukocyte influx into virus-infected tissues

1 reference

12 December 2020

Recombinant modified vaccinia virus Ankara expressing the spike glycoprotein of severe acute respiratory syndrome coronavirus induces protective neutralizing antibodies primarily targeting the receptor binding region.

1 reference

12 December 2020

Modification of promoter spacer length in vaccinia virus as a strategy to control the antigen expression

1 reference

12 December 2020

Modified Vaccinia Ankara Virus Vaccination Provides Long-Term Protection against Nasal Rabbitpox Virus Challenge

1 reference

12 December 2020

Middle East respiratory syndrome coronavirus in dromedary camels: an outbreak investigation

1 reference

12 December 2020

Genomic surveillance elucidates Ebola virus origin and transmission during the 2014 outbreak

1 reference

12 December 2020

Improving Adaptive and Memory Immune Responses of an HIV/AIDS Vaccine Candidate MVA-B by Deletion of Vaccinia Virus Genes (C6L and K7R) Blocking Interferon Signaling Pathways

1 reference

12 December 2020

Characterization of wild-type and mutant vaccinia virus M2L proteins' abilities to localize to the endoplasmic reticulum and to inhibit NF-kappaB activation during infection

1 reference

12 December 2020

Middle East respiratory syndrome coronavirus spike protein delivered by modified vaccinia virus Ankara efficiently induces virus-neutralizing antibodies

1 reference

12 December 2020

Comparative and kinetic analysis of viral shedding and immunological responses in MERS patients representing a broad spectrum of disease severity

1 reference

12 December 2020

The nonreplicating smallpox candidate vaccines defective vaccinia Lister (dVV-L) and modified vaccinia Ankara (MVA) elicit robust long-term protection

1 reference

12 December 2020

Short-term, but not post-exposure, protection against lethal orthopoxvirus challenge after immunization with modified vaccinia virus Ankara

1 reference

12 December 2020

Redundancy complicates the definition of essential genes for vaccinia virus

1 reference

12 December 2020

The orthopoxvirus 68-kilodalton ankyrin-like protein is essential for DNA replication and complete gene expression of modified vaccinia virus Ankara in nonpermissive human and murine cells.

1 reference

12 December 2020

Blockade of chemokine activity by a soluble chemokine binding protein from vaccinia virus

1 reference

12 December 2020

Interaction of F1L with the BH3 domain of Bak is responsible for inhibiting vaccinia-induced apoptosis

1 reference

12 December 2020

[Experimental research on the S-antigen in the viruses of animal smallpox]

1 reference

12 December 2020

Novel vaccine vectors for HIV-1.

1 reference

12 December 2020

Immunological and virological mechanisms of vaccine-mediated protection against SIV and HIV.

1 reference

12 December 2020

Recombinant modified vaccinia virus Ankara expressing the hemagglutinin gene confers protection against homologous and heterologous H5N1 influenza virus infections in macaques.

1 reference

12 December 2020

Enhanced CD8 T cell immunogenicity and protective efficacy in a mouse malaria model using a recombinant adenoviral vaccine in heterologous prime-boost immunisation regimes

1 reference

12 December 2020

Comparative analysis of SIV-specific cellular immune responses induced by different vaccine platforms in rhesus macaques

1 reference

12 December 2020

Immunogenicity of a highly attenuated MVA smallpox vaccine and protection against monkeypox

1 reference

12 December 2020

Selection of recombinant MVA by rescue of the essential D4R gene

1 reference

12 December 2020

Expanding the repertoire of Modified Vaccinia Ankara-based vaccine vectors via genetic complementation strategies

1 reference

12 December 2020

Highly attenuated modified vaccinia virus Ankara replicates in baby hamster kidney cells, a potential host for virus propagation, but not in various human transformed and primary cells

1 reference

12 December 2020

A soluble receptor for interleukin-1 beta encoded by vaccinia virus: a novel mechanism of virus modulation of the host response to infection

1 reference

12 December 2020

Emergence of Zaire Ebola Virus Disease in Guinea

1 reference

12 December 2020

Antibodies against MERS coronavirus in dromedary camels, United Arab Emirates, 2003 and 2013.

1 reference

12 December 2020

Designing cell lines for viral vaccine production: Where do we stand?

1 reference

12 December 2020

Oral immunization with a replication-deficient recombinant vaccinia virus protects mice against influenza

1 reference

12 December 2020

Replication of modified vaccinia virus Ankara in primary chicken embryo fibroblasts requires expression of the interferon resistance gene E3L.

1 reference

12 December 2020

A Pandemic Influenza H1N1 Live Vaccine Based on Modified Vaccinia Ankara Is Highly Immunogenic and Protects Mice in Active and Passive Immunizations

1 reference

12 December 2020

Accelerating HIV-1 Vaccine Efficacy Trials

1 reference

12 December 2020

Mutational analysis of the core, spacer, and initiator regions of vaccinia virus intermediate-class promoters

1 reference

12 December 2020

Recombinant modified vaccinia virus Ankara-based malaria vaccines

1 reference

12 December 2020

Localization and sequence of a vaccinia virus gene required for multiplication in human cells

1 reference

12 December 2020

Mousepox in the C57BL/6 strain provides an improved model for evaluating anti-poxvirus therapies

1 reference

12 December 2020

FURTHER OBSERVATIONS ON THE CULTIVATION OF VACCINE VIRUS FOR JENNERIAN PROPHYLAXIS IN MAN.

1 reference

12 December 2020

Immunization with recombinant modified vaccinia Ankara (rMVA) constructs encoding the HA or NP gene protects ponies from equine influenza virus challenge.

1 reference

12 December 2020

Modified vaccinia virus Ankara triggers type I IFN production in murine conventional dendritic cells via a cGAS/STING-mediated cytosolic DNA-sensing pathway

1 reference

12 December 2020

Zoonotic Brazilian Vaccinia virus: from field to therapy.

1 reference

12 December 2020

Nonreplicating vaccinia vector efficiently expresses recombinant genes

1 reference

12 December 2020

The complete DNA sequence of vaccinia virus

1 reference

12 December 2020

A protein particle vaccine containing multiple malaria epitopes

1 reference

12 December 2020

MVA-based H5N1 vaccine affords cross-clade protection in mice against influenza A/H5N1 viruses at low doses and after single immunization.

1 reference

12 December 2020

Ebolavirus Evolution: Past and Present

1 reference

12 December 2020

Enhanced immunogenicity for CD8+ T cell induction and complete protective efficacy of malaria DNA vaccination by boosting with modified vaccinia virus Ankara

1 reference

12 December 2020

The highly conserved orthopoxvirus 68k ankyrin-like protein is part of a cellular SCF ubiquitin ligase complex

1 reference

12 December 2020

Vectors based on modified vaccinia Ankara expressing influenza H5N1 hemagglutinin induce substantial cross-clade protective immunity

1 reference

12 December 2020

Blockade of interferon induction and action by the E3L double-stranded RNA binding proteins of vaccinia virus.

1 reference

12 December 2020

Percutaneous Vaccination as an Effective Method of Delivery of MVA and MVA-Vectored Vaccines

1 reference

12 December 2020

A novel naturally occurring tandem promoter in modified vaccinia virus ankara drives very early gene expression and potent immune responses

1 reference

12 December 2020

The rational design of an AIDS vaccine

1 reference

12 December 2020

Specificity and 6-month durability of immune responses induced by DNA and recombinant modified vaccinia Ankara vaccines expressing HIV-1 virus-like particles

1 reference

12 December 2020

Malaria vaccine developments

1 reference

12 December 2020

Origin of the West Nile virus responsible for an outbreak of encephalitis in the northeastern United States

1 reference

12 December 2020

Enhanced CD8+ T cell immune responses and protection elicited against Plasmodium berghei malaria by prime boost immunization regimens using a novel attenuated fowlpox virus

1 reference

12 December 2020

The influence of delivery vectors on HIV vaccine efficacy

1 reference

12 December 2020

Cardiac safety of Modified Vaccinia Ankara for vaccination against smallpox in a young, healthy study population

1 reference

12 December 2020

Vaccinia virus protein N2 is a nuclear IRF3 inhibitor that promotes virulence

1 reference

12 December 2020

Smallpox vaccine-induced antibodies are necessary and sufficient for protection against monkeypox virus

1 reference

12 December 2020

Deletion of gene A41L enhances vaccinia virus immunogenicity and vaccine efficacy.

1 reference

12 December 2020

Vaccinia virus: a selectable eukaryotic cloning and expression vector

1 reference

12 December 2020

Vaccinia and cowpox viruses encode a novel secreted interleukin-1-binding protein

1 reference

12 December 2020

Protective efficacy of several vaccines against highly pathogenic H5N1 avian influenza virus under experimental conditions

1 reference

12 December 2020

Poxvirus host range genes

1 reference

12 December 2020

Protective CD8+ T-cell immunity to human malaria induced by chimpanzee adenovirus-MVA immunisation

1 reference

12 December 2020

Structure and Function of A41, a Vaccinia Virus Chemokine Binding Protein

1 reference

12 December 2020

H5N1 virus: Transmission studies resume for avian flu.

1 reference

12 December 2020

MVA vaccination against smallpox: clinical tests with an attenuated live vaccinia virus strain (MVA) (author's transl)

1 reference

12 December 2020

Immunogenicities of intravenous and intramuscular administrations of modified vaccinia virus Ankara-based multi-CTL epitope vaccine for human immunodeficiency virus type 1 in mice

1 reference

12 December 2020

Identification of Restriction Factors by Human Genome-Wide RNA Interference Screening of Viral Host Range Mutants Exemplified by Discovery of SAMD9 and WDR6 as Inhibitors of the Vaccinia Virus K1L-C7L- Mutant

1 reference

12 December 2020

Chimpanzee adenovirus vaccine generates acute and durable protective immunity against ebolavirus challenge

1 reference

12 December 2020

Vaccine efficacy against malaria by the combination of porcine parvovirus-like particles and vaccinia virus vectors expressing CS of Plasmodium

1 reference

12 December 2020

Vaccinia virus immune evasion: mechanisms, virulence and immunogenicity

1 reference

12 December 2020

Innate immune sensing of modified vaccinia virus Ankara (MVA) is mediated by TLR2-TLR6, MDA-5 and the NALP3 inflammasome

1 reference

12 December 2020

Modified vaccinia virus Ankara undergoes limited replication in human cells and lacks several immunomodulatory proteins: implications for use as a human vaccine

1 reference

12 December 2020

Host range restriction of vaccinia virus in Chinese hamster ovary cells: relationship to shutoff of protein synthesis

1 reference

12 December 2020

Ectromelia, vaccinia and cowpox viruses encode secreted interleukin-18-binding proteins

1 reference

12 December 2020

The vaccinia virus K3L gene product potentiates translation by inhibiting double-stranded-RNA-activated protein kinase and phosphorylation of the alpha subunit of eukaryotic initiation factor 2

1 reference

12 December 2020

Broad protection against avian influenza virus by using a modified vaccinia Ankara virus expressing a mosaic hemagglutinin gene

1 reference

12 December 2020

Systems analysis of MVA-C induced immune response reveals its significance as a vaccine candidate against HIV/AIDS of clade C.

1 reference

12 December 2020

Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMC

1 reference

12 December 2020

Poxviruses and the evolution of host range and virulence

1 reference

12 December 2020

Vaccinia virus-mediated inhibition of type I interferon responses is a multifactorial process involving the soluble type I interferon receptor B18 and intracellular components

1 reference

12 December 2020

Enhanced immunogenicity and protective efficacy against Mycobacterium tuberculosis of bacille Calmette-Guérin vaccine using mucosal administration and boosting with a recombinant modified vaccinia virus Ankara

1 reference

12 December 2020

Isolation of vaccinia MVA recombinants using the viral F13L gene as the selective marker

1 reference

12 December 2020

Engineering of a vaccinia virus bacterial artificial chromosome in Escherichia coli by bacteriophage lambda-based recombination

1 reference

12 December 2020

Safety and immunogenicity of a modified-vaccinia-virus-Ankara-based influenza A H5N1 vaccine: a randomised, double-blind phase 1/2a clinical trial.

1 reference

12 December 2020

Cloning the vaccinia virus genome as a bacterial artificial chromosome in Escherichia coli and recovery of infectious virus in mammalian cells

1 reference

12 December 2020

Progression of pathogenic events in cynomolgus macaques infected with variola virus

1 reference

12 December 2020

Potent CD8+ T-cell immunogenicity in humans of a novel heterosubtypic influenza A vaccine, MVA-NP+M1.

1 reference

12 December 2020

Protective Efficacy of Recombinant Modified Vaccinia Virus Ankara Delivering Middle East Respiratory Syndrome Coronavirus Spike Glycoprotein

1 reference

12 December 2020

Expression of rabies virus glycoprotein from a recombinant vaccinia virus

1 reference

12 December 2020

Modified vaccinia virus Ankara induces Toll-like receptor-independent type I interferon responses

1 reference

12 December 2020

Induction of influenza (H5N8) antibodies by modified vaccinia virus Ankara H5N1 vaccine

1 reference

12 December 2020

Emerging targets and novel approaches to Ebola virus prophylaxis and treatment

1 reference

12 December 2020

1 reference

12 December 2020

Comparative experimental works on cow pox virus vaccines

1 reference

12 December 2020

Rapid expansion of CD8+ T cells in wild-type and type I interferon receptor-deficient mice correlates with protection after low-dose emergency immunization with modified vaccinia virus Ankara

1 reference

12 December 2020

The March Toward Malaria Vaccines

1 reference

12 December 2020

Human Infection with a Novel Avian Influenza A(H5N6) Virus.

1 reference

12 December 2020

General method for production and selection of infectious vaccinia virus recombinants expressing foreign genes.

1 reference

12 December 2020

E. coli beta-glucuronidase (GUS) as a marker for recombinant vaccinia viruses

1 reference

12 December 2020

Modified vaccinia virus ankara triggers chemotaxis of monocytes and early respiratory immigration of leukocytes by induction of CCL2 expression

1 reference

12 December 2020

IRF3 and IRF7 phosphorylation in virus-infected cells does not require double-stranded RNA-dependent protein kinase R or Ikappa B kinase but is blocked by Vaccinia virus E3L protein

1 reference

12 December 2020

Evaluation of a modified vaccinia virus Ankara (MVA)-based candidate pandemic influenza A/H1N1 vaccine in the ferret model

1 reference

12 December 2020

Construction and isolation of recombinant MVA.

1 reference

12 December 2020

Henipavirus mediated membrane fusion, virus entry and targeted therapeutics

1 reference

12 December 2020

The vaccinia virus C12L protein inhibits mouse IL-18 and promotes virus virulence in the murine intranasal model

1 reference

12 December 2020

West Nile fever; the clinical features of the disease and the isolation of West Nile virus from the blood of nine human cases.

1 reference

12 December 2020

Highly attenuated smallpox vaccine protects mice with and without immune deficiencies against pathogenic vaccinia virus challenge

1 reference

12 December 2020

A survey of host range genes in poxvirus genomes

1 reference

12 December 2020

Lessons learnt from the German smallpox outbreaks after World War II

1 reference

12 December 2020

Postexposure immunization with modified vaccinia virus Ankara or conventional Lister vaccine provides solid protection in a murine model of human smallpox

1 reference

12 December 2020

Airborne transmission of influenza A/H5N1 virus between ferrets

1 reference

12 December 2020

Exploring the potential of variola virus infection of cynomolgus macaques as a model for human smallpox

1 reference

12 December 2020

Reverse guanine phosphoribosyltransferase selection of recombinant vaccinia viruses

1 reference

12 December 2020

Repeated high-dose (5 × 10(8) TCID50) toxicity study of a third generation smallpox vaccine (IMVAMUNE) in New Zealand white rabbits

1 reference

12 December 2020

A Phase I, Open-Label Trial, Evaluating the Safety and Immunogenicity of Candidate Tuberculosis Vaccines AERAS-402 and MVA85A, Administered by Prime-Boost Regime in BCG-Vaccinated Healthy Adults

1 reference

12 December 2020

Viral host-range factor C7 or K1 is essential for modified vaccinia virus Ankara late gene expression in human and murine cells, irrespective of their capacity to inhibit protein kinase R-mediated phosphorylation of eukaryotic translation initiation

1 reference

12 December 2020

Protective immunity against Mycobacterium tuberculosis induced by dendritic cells pulsed with both CD8(+)- and CD4(+)-T-cell epitopes from antigen 85A.

1 reference

12 December 2020

Double-stranded RNA-binding protein E3 controls translation of viral intermediate RNA, marking an essential step in the life cycle of modified vaccinia virus Ankara

1 reference

12 December 2020

Host range deletion mutant of vaccinia virus defective in human cells

1 reference

12 December 2020

THE CULTIVATION OF VACCINE AND OTHER VIRUSES IN THE CHORIOALLANTOIC MEMBRANE OF CHICK EMBRYOS

1 reference

12 December 2020

Mapping of deletions in the genome of the highly attenuated vaccinia virus MVA and their influence on virulence

1 reference

12 December 2020

A recombinant vector derived from the host range-restricted and highly attenuated MVA strain of vaccinia virus stimulates protective immunity in mice to influenza virus

1 reference

12 December 2020

Use of ChAd3-EBO-Z Ebola virus vaccine in Malian and US adults, and boosting of Malian adults with MVA-BN-Filo: a phase 1, single-blind, randomised trial, a phase 1b, open-label and double-blind, dose-escalation trial, and a nested, randomised, doub

1 reference

12 December 2020

Modified vaccinia virus Ankara protects macaques against respiratory challenge with monkeypox virus

1 reference

12 December 2020

Differential immunogenicity of various heterologous prime-boost vaccine regimens using DNA and viral vectors in healthy volunteers

1 reference

12 December 2020

A decade after SARS: strategies for controlling emerging coronaviruses

1 reference

12 December 2020

Poxviral ankyrin proteins

1 reference

12 December 2020

Middle East Respiratory Syndrome in 3 Persons, South Korea, 2015

1 reference

12 December 2020

Vaccinia virus expression vector: coexpression of beta-galactosidase provides visual screening of recombinant virus plaques

1 reference

12 December 2020

[Changes in the vaccinia virus through continuing passages in chick embryo fibroblast cultures]

1 reference

12 December 2020

Improved adjuvanting of seasonal influenza vaccines: preclinical studies of MVA-NP+M1 coadministration with inactivated influenza vaccine

1 reference

12 December 2020

'Forgotten' NIH smallpox virus languishes on death row.

1 reference

12 December 2020

An assay to compare the infectivity of Mycobacterium tuberculosis isolates based on aerosol infection of guinea pigs and assessment of bacteriology

1 reference

12 December 2020

A review of preclinical animal models utilised for TB vaccine evaluation in the context of recent human efficacy data

1 reference

12 December 2020

Animal Models ofOrthopoxvirusInfection

1 reference

12 December 2020

Rapid generation of a mouse model for Middle East respiratory syndrome

1 reference

12 December 2020

Transient host range selection for genetic engineering of modified vaccinia virus Ankara

1 reference

12 December 2020

A Toll-like receptor-independent antiviral response induced by double-stranded B-form DNA.

1 reference

12 December 2020

Cross host transmission in the emergence of MERS coronavirus

1 reference

12 December 2020

Safety and immunogenicity of DNA/modified vaccinia virus ankara malaria vaccination in African adults

1 reference

12 December 2020

Non-replicating vaccinia vector efficiently expresses bacteriophage T7 RNA polymerase

1 reference

12 December 2020

Identification and characterization of two members of a novel class of the interleukin-1 receptor (IL-1R) family. Delineation of a new class of IL-1R-related proteins based on signaling

1 reference

12 December 2020

Experiences with immunization against orthopox viruses of humans and animals using vaccine strain MVA

1 reference

12 December 2020

Identification of immunodominant sites on the spike protein of severe acute respiratory syndrome (SARS) coronavirus: implication for developing SARS diagnostics and vaccines

1 reference

12 December 2020

1 reference

12 December 2020

Selection of recombinant vaccinia viruses on the basis of plaque formation

1 reference

12 December 2020

Sex difference in immune response to vaccination: A participant-level meta-analysis of randomized trials of IMVAMUNE smallpox vaccine

1 reference

12 December 2020

A Monovalent Chimpanzee Adenovirus Ebola Vaccine Boosted with MVA

1 reference

12 December 2020

The potential for respiratory droplet-transmissible A/H5N1 influenza virus to evolve in a mammalian host

1 reference

12 December 2020

Tandem repeats within the inverted terminal repetition of vaccinia virus DNA

1 reference

12 December 2020

Factors associated with poor outcomes among adults hospitalized for influenza in France: A three-year prospective multicenter study

1 reference

12 December 2020

Identification of vaccinia virus epitope-specific HLA-A*0201-restricted T cells and comparative analysis of smallpox vaccines.

1 reference

12 December 2020

Immunity against heterosubtypic influenza virus induced by adenovirus and MVA expressing nucleoprotein and matrix protein-1.

1 reference

12 December 2020

Development of a replication-deficient recombinant vaccinia virus vaccine effective against parainfluenza virus 3 infection in an animal model

1 reference

12 December 2020

The outbreak of West Nile virus infection in the New York City area in 1999

1 reference

12 December 2020

Interleukin-1β receptor expressed by modified vaccinia virus Ankara interferes with interleukin-1β activity produced in various virus-infected antigen-presenting cells

1 reference

12 December 2020

The Pathogenesis and Immunobiology of Mousepox

1 reference

12 December 2020

Escherichia coli gpt gene provides dominant selection for vaccinia virus open reading frame expression vectors

1 reference

12 December 2020

Vaccinia virus recombinants expressing rabiesvirus glycoprotein protect against rabies

1 reference

12 December 2020

A phase 2b randomised trial of the candidate malaria vaccines FP9 ME-TRAP and MVA ME-TRAP among children in Kenya

1 reference

12 December 2020

Novel Conserved-region T-cell Mosaic Vaccine With High Global HIV-1 Coverage Is Recognized by Protective Responses in Untreated Infection

1 reference

12 December 2020

Intracutaneous smallpox vaccination with a weak pathogenic vaccinia virus ("MVA virus")

1 reference

12 December 2020

Severe acute respiratory syndrome coronavirus spike protein expressed by attenuated vaccinia virus protectively immunizes mice

1 reference

12 December 2020

The complete genomic sequence of the modified vaccinia Ankara strain: comparison with other orthopoxviruses

1 reference

12 December 2020

Construction of poxviruses as cloning vectors: insertion of the thymidine kinase gene from herpes simplex virus into the DNA of infectious vaccinia virus

1 reference

12 December 2020

Development of eczema vaccinatum in atopic mouse models and efficacy of MVA vaccination against lethal poxviral infection

1 reference

12 December 2020

Middle East Respiratory Syndrome Infection Control and Prevention Guideline for Healthcare Facilities

1 reference

12 December 2020

Recombinant MVA expressing secreted glycoprotein D of BoHV-1 induces systemic and mucosal immunity in animal models.

1 reference

12 December 2020

The vaccinia virus K1L gene product inhibits host NF-kappaB activation by preventing IkappaBalpha degradation

1 reference

12 December 2020

Equine vaccine for West Nile virus

1 reference

12 December 2020

West Nile virus and its emergence in the United States of America

1 reference

12 December 2020

Expression of the vaccinia virus genome: analysis and mapping of mRNAs encoded within the inverted terminal repetition

1 reference

12 December 2020

HIV-DNA Given with or without Intradermal Electroporation Is Safe and Highly Immunogenic in Healthy Swedish HIV-1 DNA/MVA Vaccinees: A Phase I Randomized Trial

1 reference

12 December 2020

Improving the MVA vaccine potential by deleting the viral gene coding for the IL-18 binding protein

1 reference

12 December 2020

Recombinant modified vaccinia virus Ankara-based vaccine induces protective immunity in mice against infection with influenza virus H5N1.

1 reference

12 December 2020

Enhanced T cell-mediated protection against malaria in human challenges by using the recombinant poxviruses FP9 and modified vaccinia virus Ankara

1 reference

12 December 2020

F-box-like domains are present in most poxvirus ankyrin repeat proteins

1 reference

12 December 2020

The vaccinia virus F1L protein interacts with the proapoptotic protein Bak and inhibits Bak activation

1 reference

12 December 2020

A candidate HIV/AIDS vaccine (MVA-B) lacking vaccinia virus gene C6L enhances memory HIV-1-specific T-cell responses

1 reference

12 December 2020

Orthopoxvirus IL-18 binding proteins: affinities and antagonist activities

1 reference

12 December 2020

Vaccinia virus host range genes

1 reference

12 December 2020

The ankyrin repeat as molecular architecture for protein recognition

1 reference

12 December 2020

Highly attenuated poxvirus vectors

1 reference

12 December 2020

An orthopoxvirus-based vaccine reduces virus excretion after MERS-CoV infection in dromedary camels

1 reference

12 December 2020

Recombinant modified vaccinia virus Ankara expressing antigen 85A boosts BCG-primed and naturally acquired antimycobacterial immunity in humans

1 reference

12 December 2020

Ectromelia virus: the causative agent of mousepox

1 reference

12 December 2020

Oral vaccination of the fox against rabies using a live recombinant vaccinia virus.

1 reference

12 December 2020

New vaccinia virus promoter as a potential candidate for future vaccines

1 reference

12 December 2020

Recombination-mediated genetic engineering of a bacterial artificial chromosome clone of modified vaccinia virus Ankara (MVA).

1 reference

12 December 2020

Modified vaccinia virus Ankara protein F1L is a novel BH3-domain-binding protein and acts together with the early viral protein E3L to block virus-associated apoptosis

1 reference

12 December 2020

Codelivery of Envelope Protein in Alum with MVA Vaccine Induces CXCR3-Biased CXCR5+ and CXCR5- CD4 T Cell Responses in Rhesus Macaques

1 reference

12 December 2020

Potent neutralization of severe acute respiratory syndrome (SARS) coronavirus by a human mAb to S1 protein that blocks receptor association

1 reference

12 December 2020

Human infection with a zoonotic orthopoxvirus in the country of Georgia

1 reference

12 December 2020

Near death experiences: poxvirus regulation of apoptotic death

1 reference

12 December 2020

Smallpox vaccines: targets of protective immunity

1 reference

12 December 2020

Patterns of viral replication correlate with outcome in simian immunodeficiency virus (SIV)-infected macaques: effect of prior immunization with a trivalent SIV vaccine in modified vaccinia virus Ankara.

1 reference

12 December 2020

Human infection with MERS coronavirus after exposure to infected camels, Saudi Arabia, 2013.

1 reference

12 December 2020

A Multicenter, Open-Label, Controlled Phase II Study to Evaluate Safety and Immunogenicity of MVA Smallpox Vaccine (IMVAMUNE) in 18-40 Year Old Subjects with Diagnosed Atopic Dermatitis.

1 reference

12 December 2020

Cowpox virus and other members of the orthopoxvirus genus interfere with the regulation of NF-kappaB activation

1 reference

12 December 2020

Easy and efficient protocols for working with recombinant vaccinia virus MVA.

1 reference

12 December 2020

Safety and Immunogenicity of Modified Vaccinia Ankara-Bavarian Nordic Smallpox Vaccine in Vaccinia-Naive and Experienced Human Immunodeficiency Virus-Infected Individuals: An Open-Label, Controlled Clinical Phase II Trial.

1 reference

12 December 2020

West Nile virus infection and immunity

1 reference

12 December 2020

Ebola: lessons learned and future challenges for Europe

1 reference

12 December 2020

Elucidating and minimizing the loss by recombinant vaccinia virus of human immunodeficiency virus gene expression resulting from spontaneous mutations and positive selection

1 reference

12 December 2020